|Slideshows|June 17, 2013

Slide Show: Decolonization and MRSA Reduction

A new study shows that using germ-killing soap and ointment on all ICU patients can reduce bloodstream infections by up to 44 percent and significantly reduce the presence of methicillin-resistant Staphylococcus aureus (MRSA).

Newsletter

Stay prepared and protected with the Infection Control Today newsletter, delivering essential updates, best practices, and expert insights for infection prevention professionals.

Subscribe

Related Content

Patients in Cambodia. (Image by Brayden Unger via AI)

Special Feature. Three Days in Cambodia: What a Volunteer Saw Before He Had the Words

ByBrenna Doran, PhD, MA, ACC, CIC, AL-CIP,Brayden Unger

July 22nd 2026

Hepatitis C written on a page. (Adobe Stock 112538011 by Vitalii Vodolazskyi)

Atea Completes Enrollment in Phase 3 Hepatitis C Trial Evaluating Bemnifosbuvir and Ruzasvir

ByInfection Control Today® Editorial Staff

July 21st 2026

Contagious Conversations: Global Infection Prevention Leaders Say the Future of IPC Depends on Diverse Career Pathways

ByTori Whitacre Martonicz, MA

July 21st 2026

FDA Says False-Positive Test Does Not Change Cyclospora Outbreak Investigation

ByTori Whitacre Martonicz, MA

July 20th 2026

Sterile Processing Perspectives with Marjorie Wall, EDBA, MLOS, CRCST, CIS, CHL, CSSBB

Beyond Sterility: Why Coordination Is Becoming the New Measure of Sterile Processing Performance

ByMarjorie Wall, EDBA, CRCST, CIS, CHL, CSSBB

July 20th 2026

Latest CME

Video

A Shield of Protection: Unmet Needs in COVID-19 Prevention and Control

Onyema Ogbuagu, MD, FACP, FIDSA; Jeffery A. Goad, PharmD, MPH; William P. Hanage, PhD

Multimedia

Empowering HIV Management: Evidence-Based Prevention and Treatment Strategies

Onyema Ogbuagu, MD, FACP, FIDSA

Slide Show: Decolonization and MRSA Reduction

Related Content

Special Feature. Three Days in Cambodia: What a Volunteer Saw Before He Had the Words

Atea Completes Enrollment in Phase 3 Hepatitis C Trial Evaluating Bemnifosbuvir and Ruzasvir

Contagious Conversations: Global Infection Prevention Leaders Say the Future of IPC Depends on Diverse Career Pathways

FDA Says False-Positive Test Does Not Change Cyclospora Outbreak Investigation

Beyond Sterility: Why Coordination Is Becoming the New Measure of Sterile Processing Performance

Latest CME

A Shield of Protection: Unmet Needs in COVID-19 Prevention and Control

Empowering HIV Management: Evidence-Based Prevention and Treatment Strategies

Trending on Infection Control Today

Special Feature. Three Days in Cambodia: What a Volunteer Saw Before He Had the Words

Contagious Conversations: Global Infection Prevention Leaders Say the Future of IPC Depends on Diverse Career Pathways

FDA Says False-Positive Test Does Not Change Cyclospora Outbreak Investigation

Beyond Sterility: Why Coordination Is Becoming the New Measure of Sterile Processing Performance

Atea Completes Enrollment in Phase 3 Hepatitis C Trial Evaluating Bemnifosbuvir and Ruzasvir